The impact of patient characteristics on enzalutamide pharmacokinetics and how this relates to treatment toxicity and efficacy in metastatic prostate cancer patients

PURPOSE: The aim of the study is to investigate the influence of patient characteristics, age and body mass index (BMI), on pharmacokinetics of enzalutamide, and to study the relationships between drug exposure and enzalutamide efficacy and toxicity, in mCRPC patients. METHODS: Data were collected i...

Descripción completa

Detalles Bibliográficos
Autores principales: Benoist, Guillemette E., van Oort, Inge M., Burger, David M., Mehra, Niven, van Erp, Nielka P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125069/
https://www.ncbi.nlm.nih.gov/pubmed/32076807
http://dx.doi.org/10.1007/s00280-020-04039-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125069/
https://www.ncbi.nlm.nih.gov/pubmed/32076807
http://dx.doi.org/10.1007/s00280-020-04039-7

Ejemplares similares